Key facts
- This page summarizes Sireesh Appajosyula's Form 4 filing for Hepion Pharmaceuticals, Inc. (HEPA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 Aug 2026, 21:36.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Purchase